BALAXI PHARMA LTD (BALAXI)

NSE: ₹24.65
Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 80.68 65.96 54.72 60.79 59.83 65.62 77.38 73.29 76.27 70.74 56.18 72.54
YOY Revenue Growth % -9.45% -20.33% -36.65% -29.79% -25.84% -0.51% 41.41% 20.57% 27.46% 7.8% -27.41% -1.02%
Other Income -0.22 -1.01 0.28 -0.13 -1.79 -1.85 -4.11 3.94 -1.69 -1.78 1.59 0.10
Total Income 80.46 64.95 55.00 60.65 58.05 63.77 73.27 77.23 74.57 68.97 57.76 72.64
Total Expenses + 67.94 57.12 43.96 47.13 46.37 55.54 66.79 69.30 64.91 68.06 56.38 71.03
Cost of Materials Consumed 51.08 40.31 29.12 30.36 28.88 38.14 44.17 43.84 39.56 39.56 29.03 41.74
Employee Benefit Expense 6.88 6.89 6.56 7.70 6.89 8.10 8.43 9.31 8.63 8.41 8.93 10.21
Other Expenses 9.98 9.91 8.27 9.07 10.59 9.30 14.19 16.15 15.53 18.62 17.04 17.50
Operating Profit 12.74 8.84 10.76 13.66 13.47 10.09 10.59 3.99 11.36 2.68 -0.21 1.51
OPM % 15.8% 13.4% 19.7% 22.5% 22.5% 15.4% 13.7% 5.4% 14.9% 3.8% -0.4% 2.1%
Profit Before Tax + 11.07 -39.41 15.66 14.27 11.49 7.37 5.56 6.07 9.66 0.90 1.38 1.61
Tax Expense 2.97 1.93 1.23 0.68 0.56 0.89 0.97 0.71 1.03 0.61 1.17 1.30
Tax % 26.8% - 7.9% 4.8% 4.9% 12.1% 17.5% 11.6% 10.6% 67.9% 84.8% 81.1%
Profit After Tax 8.10 -41.34 14.43 13.59 10.93 6.48 4.59 5.36 8.64 0.29 0.21 0.31
EPS (Basic) 8.01 -40.49 14.10 13.29 10.41 1.17 0.84 0.97 1.56 0.05 0.04 0.06

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 292.56 241.29 336.43 279.39 231.33 45.63
YOY Revenue Growth % 21.25% -28.28% 20.42% 20.77% 406.95% -
Other Income -3.72 -2.65 2.64 4.97 2.23 2.81
Total Income 288.84 238.65 339.07 284.36 233.56 48.44
Total Expenses + 260.18 194.56 279.89 229.18 188.92 39.56
Cost of Materials Consumed 165.70 128.68 202.42 195.60 172.15 33.58
Employee Benefit Expense 34.74 27.38 28.95 12.47 8.47 2.10
Other Expenses 54.91 38.51 48.53 21.12 8.30 3.89
Operating Profit 32.39 46.73 56.54 50.20 42.41 6.07
OPM % 11.1% 19.4% 16.8% 18% 18.3% 13.3%
Profit Before Exceptional 28.67 40.31 56.92 54.52 44.33 8.87
Exceptional Items 0.00 -38.29 0.00 0.00 0.00 0.00
Profit Before Tax + 28.67 2.02 56.92 54.52 44.33 8.87
Tax Expense 3.60 4.40 10.96 6.86 6.19 2.77
Tax % 12.6% 218.4% 19.3% 12.6% 14% 31.2%
Profit After Tax 25.07 -2.39 45.96 47.66 38.14 6.10
EPS (Basic) 4.54 -2.32 45.81 47.66 38.14 8.12

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 67.58 48.17 46.16 0.00 0.00 0.00
Property, Plant & Equipment 14.24 14.78 16.18 0.00 0.00 0.00
Capital Work in Progress 22.07 2.31 2.83 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 26.75 26.10 25.22 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 242.77 210.17 193.51 0.00 0.00 0.00
Inventories 78.48 82.17 105.02 0.00 0.00 0.00
Trade Receivables 110.80 55.71 53.43 0.00 0.00 0.00
Cash and Cash Equivalents 39.40 62.29 28.21 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 11.04 10.90 10.18 0.00 0.00 0.00
Other Equity 220.69 190.47 172.70 0.00 0.00 0.00
Non-Current Liabilities 24.07 2.78 3.66 0.00 0.00 0.00
Current Liabilities 54.53 54.20 53.13 0.00 0.00 0.00
Total Liabilities 78.61 56.98 56.79 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -35.00 4.87 6.08 34.14 0.00 0.00
Cash from Investing Activities -21.76 -1.05 -10.57 -28.45 0.00 0.00
Cash from Financing Activities 33.88 30.25 25.51 -0.16 0.00 0.00
Net Increase/Decrease in Cash 39.40 34.07 21.02 5.54 0.00 0.00